Gary R. Matzke
- Pharmacology top 0.5%
- Infectious Diseases top 2%
- Nephrology top 1%
- Epidemiology top 5%
- Pediatrics, Perinatology and Child Health top 2%
- Co-authors
- David R.P. GuayReginald F. FryeC E HalstensonGeorge G. ZhanelWilliam F. KeaneCharles E. HalstensonJohn A. OpsahlW. F. Keane
- Topics
- Antibiotics Pharmacokinetics and Efficacy (54 papers)Pharmacogenetics and Drug Metabolism (22 papers)Pharmacological Effects and Toxicity Studies (22 papers)
- Journals
- SHILAP Revista de lepidopterologíaClinical Infectious DiseasesKidney International
- Partner nations
- United StatesGermanyArgentina
In The Last Decade
Gary R. Matzke
142 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 139
- Pharmacology 1.5k
- Infectious Diseases 683
- Nephrology 673
- Epidemiology 640
- Pediatrics, Perinatology and Child Health 634
Countries citing papers authored by Gary R. Matzke
This map shows the geographic impact of Gary R. Matzke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Matzke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Matzke more than expected).
Fields of papers citing papers by Gary R. Matzke
This network shows the impact of papers produced by Gary R. Matzke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Matzke. The network helps show where Gary R. Matzke may publish in the future.
Co-authorship network of co-authors of Gary R. Matzke
This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Matzke. A scholar is included among the top collaborators of Gary R. Matzke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Matzke. Gary R. Matzke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Improvements in MBD lab outcomes associated with improved pharmaceutical care in hemodialysis patients. | 1 |
| 2 | 87 | |
| 3 | 53 | |
| 4 | 177 | |
| 5 | 1 | |
| 6 | 17 | |
| 7 | 8 | |
| 8 | 39 | |
| 9 | 29 | |
| 10 | 18 | |
| 11 | 125 | |
| 12 | 28 | |
| 13 | 37 | |
| 14 | 14 | |
| 15 | 16 | |
| 16 | 23 | |
| 17 | 21 | |
| 18 | 35 | |
| 19 | Renal hemodynamic and humoral effects of pinacidil and hydralazine in essential hypertension | 2 |
| 20 | Acute phenytoin and primidone intoxication | 1 |
About Gary R. Matzke
Gary R. Matzke is a scholar working on Geriatrics and Gerontology, Pharmacology and Pharmacology, having authored 147 papers that have together received 4.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (54 papers), Pharmacogenetics and Drug Metabolism (22 papers) and Pharmacological Effects and Toxicity Studies (22 papers). The work is most often cited by research in Nephrology (673 citations), Pharmacology (1.5k citations) and Applied Microbiology and Biotechnology (150 citations). Gary R. Matzke has collaborated with scholars based in United States, Germany and Argentina. Frequent co-authors include David R.P. Guay, Reginald F. Frye, C E Halstenson, George G. Zhanel, William F. Keane, Charles E. Halstenson, John A. Opsahl, W. F. Keane, R. McGory and Phillip K. Peterson. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.